PharmEasy to buy Thyrocare, Deal valued at Rs 6,000 cr

Online medical store PharmEasy's parent entity will acquire a 66% stake in Thyrocare Technologies Ltd, one of the largest diagnostics chains in India. PharmEasy will pick up stake in Thyrocare at ₹1,300 per share, valuing the deal at ₹4,546 crore. The transaction is subject to regulatory and other applicable customary approvals.

The PharmEasy-Thyrocare deal comes at a time when the online pharmacy sector is witnessing a boom. PharmEasy in a statement said, the collaboration is unique and transformative for the Indian healthcare sector, consumers and the entire healthcare ecosystem.

The statement added that the synergies of both, India’s largest digital health platform and one of the largest, cost-effective diagnostics solution providers will accelerate the delivery of high-quality diagnostic and OPD services to nearly 800mn Indians.